Bioniz Logo

Skip to content
  • Team
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Science
  • Pipeline
    • BNZ-1
    • BNZ-2
    • BNZ-3
  • News
  • Contact
Bioniz - Pipeline

Pipeline

  • Pipeline
  • BNZ-1
  • BNZ-2
  • BNZ-3

Product Candidates/Indications Research Pre-clinical Phase 1 Phase 2 Phase 3 Partnership
BNZ-1 (IL-2, IL-9, IL-15)

option to buy
Cutaneous T-cell Lymphoma (CTCL)
85.5%
Alopecia Areata
64%
BNZ-2 (IL-15, IL-21) subcutaneous delivery
Celiac Disease
45%
 
Inflammatory Bowel Disease (s.c.)
18%
 
BNZ-3 (IL-15, IL-21) oral delivery
Celiac Disease
10%
 

Product Candidates/Indications Phase Partnership
BNZ-1 (IL-2, IL-15)

option to buy
Cutaneous T-cell Lymphoma (CTCL)
Phase 2
Alopecia Areata
Phase 1 Completed
BNZ-2 (IL-15, IL-21) subcutaneous delivery
Celiac Disease
Phase 1
 
Inflammatory Bowel Disease (s.c.)
Research
 
BNZ-3 (IL-15, IL-21) oral delivery
Celiac Disease
Research
 
Copyright 2021 Bioniz. All Rights Reserved.
  • Team
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Science
  • Pipeline
    • BNZ-1
    • BNZ-2
    • BNZ-3
  • News
  • Contact